Oncobiologics (NASDAQ:ONS) and Aevi Genomic Medicine (NASDAQ:GNMX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings and dividends. Volatility and Risk Oncobiologics has a beta of -0.27, indicating that its share price is […]
